The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of them report good results, and half of the stocks have a price-earnings ratio of less than 30 times.

Key Data Concepts:   

? These are the company names, stock quotes, topics, and entities related to this data.

000513 000925 002014 002527 002581 300122 300485 300601 300713 300841 Beijing Science Sun Pharmaceutical Chengdu Kanghua Biological Products China Industrial Securities Chongqing Zhifei Biological Products Huangshan Novel Joincare Pharmaceutical Group Industry Livzon Pharmaceutical Group Shandong Sinobioway Biomedicine Shanghai Step Electric Corporation Shenzhen Kangtai Biological Products Shenzhenrease Technology Unittec Accounting, Audit Earnings Annual, Special Corporate Meeting Annual Report Research, Development Health, Beauty Product Pharmaceutical Construction, Property Design, Engineering Manufacturing, Engineering Market, Exchange Securities Stocks Diseases, Conditions Epidemic Medicine Vaccines Workplace Health, Safety House, Home Government Biology Technology, Engineering Health

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets

Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!

Already have an account?
Login

Home » News » The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of them report good results, and half of the stocks have a price-earnings ratio of less than 30 times.